Nureca IPO Listing Today: The investors who paid attention to the advice of Zee Business Managing Editor Anil Singhvi made handsome listing gains in this public issue. At the time of the launch of the Initial Public Offering (IPO) of Nureca Limited, the Market Guru had advised investment in this issue for good listing gains. He had also recommended this stock for investors who wanted invest in this stock with a long term perspective.    

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Nureca Limited listing was a bumper one on Thursday. The stock was listed at Rs 615 on the NSE. The Nureca share price soared after listing and were trading around 645.75 minutes before the market closing time. This was almost 61 per cent or Rs 245 above the issue price.  

See Zee Business Live TV Streaming Below:

Zee Business Managing Editor Anil Singhvi had earlier recommended that investors buy into Nureca IPO for good listing gains. The issue price was Rs 400. Singhvi had praised the company saying that the financial over the last 6 months were outstanding. The profit margins were a staggering 30 per cent, he had said. 

The Managing Editor had recommended investment in this stock for good listing gains. Nureca IPO was also recommended for long term investment. Nureca IPO has been subscribed 39.93 times.   

Watch Zee Business Tweet Video Below:

Nureca Stock Trading Strategy  

The strategy in Nureca stock is simple, Singhvi had said. The investors are advised to protect listing gains of around 20 per cent. After this they have to trail the stop loss. He said that if the listing is above RS 550, then the stop loss should be kept with Rs 30 margin. For example, if the listing is at Rs 600 then the stop loss should be Rs 570, he had explained.   

The investors should hold the stock and the stop loss should be trailed accordingly, he said.  

He had said that there could be some fresh buying even after the listing as the operations of the company are new age.   

Nureca is into the business of healthcare and wellness. The Production Linked Incentive (PLI) scheme announced on Wednesday for medical equipment manufacturing may help it even though it is not into manufacturing.